Thyme Care, Inc.

Venture-backed company · Series D+· Nashville, TNpearlhealth.com

Join 5,000+ providers and unlock the full value of value-based care with actionable insights, financial modeling, and AI workflow automation. Trusted across 40+ states.

Rounds on record
3
Latest round
Sep 2, 2026
Series E
Form D industry: Other Health Care
More
Ask DFX about thisView relationshipsFinancing historyInvestorsOwnership and outcomes
As of · the latest observation of this company; each round carries its own date

7 additional officers and directors

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. Round
    announced

    Announced a Series D or later on 2 Sep 2026.

    A company that just raised has fresh capital, a new board and new vendors to choose.

    FactPress release wires (PR Newswire, GlobeNewswire)For Investors, lenders, service providersFinancing history →
  2. 2 investors
    named

    2 investors on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
  3. 8 directors
    board

    8 directors on record from Form D filings and board-seat attributions.

    The board is who decides on the next round and on a sale.

    FactSEC Form D related personsFor Investors, acquirersPeople →
Drawing the relationship network…

Facts

Year of incorporation
2020sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
3
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2

Financing history

3 rounds
  1. Sep 2, 2026
    Series E · amount undisclosed
    CVS Health Ventures (participant)
    Fact Press release · “Thyme Care Closes $125+ Million Series E, Establishes Thyme Companies to Broaden Its Impact Across the Oncology Ecosystem”
  2. Apr 4, 2025
    Form D equity offering · $97.0M (form d sold) · 14 investors
    Fact Form D · “Thyme Care, Inc. filed Form D: $97,047,918 sold of $100,000,005, Other Health Care”
  3. Jul 11, 2024
    Form D equity offering · $54.5M (form d sold) · 13 investors
    Fact Form D · “Thyme Care, Inc. filed Form D: $54,499,996 sold of $54,499,996, Other Health Care”

Investors on record

2 edges

Ownership and outcomes

none on record
Outcome stated by investors

Listed on 1 firm portfolio page; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.

Evidence: 1 listingeach firm's own card, as read
No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.

Credit relationships

none on record
No lender position matched to this company.

People

5 officers, 8 directors
Show all 6 officers and directors

Timeline

3 events
  1. Sep 2, 2026
    Thyme Care announced Series E
    Round announced Fact Press release
  2. Sep 25, 2025
    Thyme Care, Inc. filed Form D: $97,047,918 sold of $100,000,005, Other Health Care
    Form D filed Fact Form D
  3. Jul 23, 2024
    Thyme Care, Inc. filed Form D: $54,499,996 sold of $54,499,996, Other Health Care
    Form D filed Fact Form D

Evidence

36 observations
Every observation on this company
  • Description: Sep 15, 2026 Fact Company website
  • Entity type: Corporation Sep 25, 2025 Fact Form D
  • Entity type: Corporation Jul 23, 2024 Fact Form D
  • Form D industry group: Sep 25, 2025 Fact Form D
  • Form D industry group: Jul 23, 2024 Fact Form D
  • Amendment: false Sep 25, 2025 Fact Form D
  • Amendment: false Jul 23, 2024 Fact Form D
  • Revenue range (Form D): Decline to Disclose Sep 25, 2025 Fact Form D
  • Revenue range (Form D): Decline to Disclose Jul 23, 2024 Fact Form D
  • Incorporated: overFiveYears Sep 25, 2025 Fact Form D
  • Incorporated: withinFiveYears Jul 23, 2024 Fact Form D
  • Jurisdiction: Delaware Sep 25, 2025 Fact Form D
  • Jurisdiction: Delaware Jul 23, 2024 Fact Form D
  • Amount sold (Form D): $97.0M Sep 25, 2025 Fact Form D
  • Amount sold (Form D): $54.5M Jul 23, 2024 Fact Form D
  • Offering amount (Form D): $100M Sep 25, 2025 Fact Form D
  • Offering amount (Form D): $54.5M Jul 23, 2024 Fact Form D
  • Exemptions: 06b Sep 25, 2025 Fact Form D
  • Exemptions: 06b Jul 23, 2024 Fact Form D
  • First sale: 2025-04-04 Sep 25, 2025 Fact Form D
  • First sale: 2024-07-11 Jul 23, 2024 Fact Form D
  • Investors (Form D): 14 Sep 25, 2025 Fact Form D
  • Investors (Form D): 13 Jul 23, 2024 Fact Form D
  • Minimum investment (Form D): 0 Sep 25, 2025 Fact Form D
  • Minimum investment (Form D): 0 Jul 23, 2024 Fact Form D
  • Securities offered: equity Sep 25, 2025 Fact Form D
  • Securities offered: equity Jul 23, 2024 Fact Form D
  • Office address: Sep 25, 2025 Fact Form D
  • Office address: Jul 23, 2024 Fact Form D
  • Listed on portfolio page: Alleycorp Advisers, LLC Sep 30, 2026 Fact Firm website
  • Listed on portfolio page: Alleycorp Advisers, LLC Sep 16, 2026 Fact Firm website
  • Listed on portfolio page: Alleycorp Advisers, LLC Sep 15, 2026 Fact Firm website
  • Round announced: Series E Sep 2, 2026 Fact Press release
  • Website status: ok Sep 15, 2026 Fact Company website
  • Site title: Sep 15, 2026 Fact Company website
  • Year of incorporation: 2020 Jul 23, 2024 Fact Form D

Record history

3 dated events on the change ledger, latest event first
  • Round announced
    2026-09-02source on record
  • Form D filed
    2025-09-25source on record
  • Form D filed
    2024-07-23source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.